Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析

◆英語タイトル:Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15753
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Henry Schein Inc (HSIC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Henry Schein Inc (Henry Schein) is a provider of health care products and services to dental and medical practitioners. Its product portfolio consists of dental and medical products, software and technology and other value-added services. The company distributes both generic and branded drugs. Henry Schein supplies its products and provides services to dental practitioners and laboratories, physician practices, and government and other institutions through a centralized and automated distribution network. The company, along with its subsidiaries, operates in Germany, Canada, France, Switzerland, the UK and the US. It also manages affiliates in Iceland, Saudi Arabia and Turkey. Henry Schein is headquartered in New York, the US.

Henry Schein Inc Key Recent Developments

Mar 12,2019 Henry Schein to showcase comprehensive portfolio of solutions for Health Care Professionals at the 38th International Dental Show
Feb 26,2019 Henry Schein named one of the 2019 World’s most ethical companies by Ethisphere
Feb 21,2019 Zahn Dental Announces New Solutions, Live Educational Events, and Introduction of Zahn Digital Solutions at LMT Lab Day, February 21 – 23, in Chicago, IL
Feb 21,2019 Henry Schein One Unveils Entertaining Patient Theater Experience With New Booth At Chicago Midwinter Dental Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Henry Schein Inc – Key Facts
Henry Schein Inc – Key Employees
Henry Schein Inc – Key Employee Biographies
Henry Schein Inc – Major Products and Services
Henry Schein Inc – History
Henry Schein Inc – Company Statement
Henry Schein Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Henry Schein Inc – Business Description
Business Segment: Healthcare Distribution
Overview
Performance
Business Segment: Technology and Value Added Services
Overview
Performance
Geographical Segment: Other Countries
Performance
Overview
Geographical Segment: The US
Performance
Henry Schein Inc – Corporate Strategy
Henry Schein Inc – SWOT Analysis
SWOT Analysis – Overview
Henry Schein Inc – Strengths
Henry Schein Inc – Weaknesses
Henry Schein Inc – Opportunities
Henry Schein Inc – Threats
Henry Schein Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Henry Schein Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Henry Schein Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Henry Schein Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 12, 2019: Henry Schein to showcase comprehensive portfolio of solutions for Health Care Professionals at the 38th International Dental Show
Feb 26, 2019: Henry Schein named one of the 2019 World’s most ethical companies by Ethisphere
Feb 21, 2019: Zahn Dental Announces New Solutions, Live Educational Events, and Introduction of Zahn Digital Solutions at LMT Lab Day, February 21 – 23, in Chicago, IL
Feb 21, 2019: Henry Schein One Unveils Entertaining Patient Theater Experience With New Booth At Chicago Midwinter Dental Meeting
Feb 20, 2019: Henry Schein reports record fourth quarter and full year 2018 financial results
Jan 21, 2019: Save the Date: Henry Schein to Host the Dental Service Organization Education Forum, Featuring a Rich Lineup of Speakers and Courses
Jan 21, 2019: Save the Date Henry Schein to Host the Dental Service Organization Education Forum Featuring a Rich Lineup of Speakers and Courses
Jan 08, 2019: Henry Schein Announces Record Date, Distribution Date And Anticipated When-Issued Trading Market For Spin-Off Of Animal Health Business
Dec 17, 2018: CareCredit now integrated into Henry Schein’s Dental and Veterinary Practice Management Software Solutions
Dec 03, 2018: Henry Schein Disaster Relief Hotline is open to support customers affected by earthquake in Alaska
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Henry Schein Inc, Key Facts
Henry Schein Inc, Key Employees
Henry Schein Inc, Key Employee Biographies
Henry Schein Inc, Major Products and Services
Henry Schein Inc, History
Henry Schein Inc, Other Locations
Henry Schein Inc, Subsidiaries
Henry Schein Inc, Key Competitors
Henry Schein Inc, Ratios based on current share price
Henry Schein Inc, Annual Ratios
Henry Schein Inc, Annual Ratios (Cont...1)
Henry Schein Inc, Annual Ratios (Cont...2)
Henry Schein Inc, Interim Ratios
Henry Schein Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Henry Schein Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Henry Schein Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Henry Schein Inc, Performance Chart (2014 - 2018)
Henry Schein Inc, Ratio Charts
Henry Schein Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Henry Schein Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • City of Hope-製薬・医療分野:企業M&A・提携分析
    Summary City of Hope (COH) is a biomedical research organization that offers cancers, diabetes and infectious diseases treatment services. The organization offers services in the fields of anesthesiology, interventional radiology, surgery, donor matching and marrow transplants, rehabilitation servic …
  • Celyad SA (CYAD):企業の財務・戦略的SWOT分析
    Summary Celyad SA (Celyad), formerly Cardio3 BioSciences, is a clinical-stage biopharmaceutical company that offers discovery and development of engineered cell therapies. The company offers C-Cure, a cell-based reparative therapy to treat heart failure. It offers C-Cathez, an intraventricular injec …
  • Enlivant Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Enlivant Inc (Enlivant) is an assisted living facilities provider that offers senior living residence services. The center provides senior housing options, choosing assisted living and short term stay services. It also provides attentive and individualized care services. Enlivant offers assi …
  • The Hartford Financial Services Group, Inc.:戦略・SWOT・企業財務分析
    The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • TransCanada Corporation (TRP):電力:M&Aディール及び事業提携情報
    Summary TransCanada Corp (TransCanada) is an energy infrastructure company. It develops and operates energy infrastructure, such as natural gas and liquids pipelines, power generation and gas storage facilities. The company also provides gas storage related services and operates in the regulated and …
  • NaviNet Inc:企業の戦略的SWOT分析
    NaviNet Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • GCL-Poly Energy Holdings Ltd (3800)-エネルギー分野:企業M&A・提携分析
    Summary GCL-Poly Energy Holdings Ltd. (GCL) is a provider of solar photovoltaic (PV) material and professional PV system solutions. The company produces and supplies high-quality solar grade and semiconductor grade polysilicon raw materials and silicon wafers to companies operating in the solar indu …
  • Actividades de Construccion y Servicios SA:企業のM&A・事業提携・投資動向
    Actividades de Construccion y Servicios SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Actividades de Construccion y Servicios SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • C&A:戦略・SWOT・企業財務分析
    C&A - Strategy, SWOT and Corporate Finance Report Summary C&A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing …
  • iBio Inc (IBIO):医療機器:M&Aディール及び事業提携情報
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Cocrystal Pharma Inc (COCP):製薬・医療:M&Aディール及び事業提携情報
    Summary Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a clinical stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline produc …
  • Givaudan SA:戦略・SWOT・企業財務分析
    Givaudan SA - Strategy, SWOT and Corporate Finance Report Summary Givaudan SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • China Resources Land Limited:企業の戦略・SWOT・財務情報
    China Resources Land Limited - Strategy, SWOT and Corporate Finance Report Summary China Resources Land Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Kuwait Petroleum International Ltd:企業の戦略的SWOT分析
    Kuwait Petroleum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Sumitomo Mitsui Banking Corp:企業のM&A・事業提携・投資動向
    Sumitomo Mitsui Banking Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sumitomo Mitsui Banking Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Shanghai SECCO Petrochemical Co Ltd:企業の戦略的SWOT分析
    Shanghai SECCO Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Exicure Inc-製薬・医療分野:企業M&A・提携分析
    Summary Exicure Inc (Exicure), formerly AuraSense Therapeutics LLC, is a biotechnology company that develops and commercializes immunomodulatory and gene silencing drugs based on 3-dimensional spherical nucleic acid (SNA) constructs. Its technology portfolio includes SNA gene regulation platform and …
  • BioVendor – Laboratorni Medicina as:製薬・医療:M&Aディール及び事業提携情報
    Summary BioVendor - Laboratorni Medicina as (BioVendor) is a developer and manufacturer of immunoassays, recombinant protiens, antibodies and endotoxin-removal products. The company provides products such as immunoassays, proteins, antibodies, endotoxin removal products, endotoxin detection products …
  • Immunovia AB (IMMNOV):企業の財務・戦略的SWOT分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆